1. Home
  2. ASR vs ABVX Comparison

ASR vs ABVX Comparison

Compare ASR & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Aeroportuario del Sureste S.A. de C.V.

ASR

Grupo Aeroportuario del Sureste S.A. de C.V.

HOLD

Current Price

$295.72

Market Cap

9.2B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$114.79

Market Cap

9.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASR
ABVX
Founded
1996
2013
Country
Mexico
France
Employees
1882
67
Industry
Aerospace
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
9.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ASR
ABVX
Price
$295.72
$114.79
Analyst Decision
Buy
Buy
Analyst Count
4
13
Target Price
$365.00
$131.31
AVG Volume (30 Days)
59.0K
767.5K
Earning Date
04-22-2026
03-23-2026
Dividend Yield
12.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.44
$52.14
Revenue Next Year
$9.69
$4,132.27
P/E Ratio
$18.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$292.35
$5.59
52 Week High
$381.52
$148.83

Technical Indicators

Market Signals
Indicator
ASR
ABVX
Relative Strength Index (RSI) 34.88 45.18
Support Level N/A $107.29
Resistance Level $318.64 $129.73
Average True Range (ATR) 6.82 4.94
MACD -0.18 -0.04
Stochastic Oscillator 11.18 39.77

Price Performance

Historical Comparison
ASR
ABVX

About ASR Grupo Aeroportuario del Sureste S.A. de C.V.

Grupo Aeroportuario del Sureste SAB de CV and its subsidiaries hold concessions to operate, maintain, and develop airports in the southeast region of Mexico. As an operator of airports, it charges airlines, passengers, and other users fees for using the airports' facilities. The group also derives rental and other income from commercial activities conducted at its airports, such as the leasing of space to restaurants and retailers. The company's operating segments are Cancun, which generates majority revenue, Aerostar, Airplan, Merida, Villahermosa, Holding and Services, and Others.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: